Skip to main content
Caplight Logo









Amai Proteins

Amai Proteins

Private
IsraelFrontier & Industrial Techhttps://amaiproteins.com/

Last Round

Series A

Jan 10, 2023

Total Funding Raised

$135.75M

Company Overview

Amai Proteins is a food technology company that develops novel designer proteins, including its flagship hyper-sweet protein sweelin™, to help the food and beverage industry reduce sugar content.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, ML Platforms, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

sugar substitutesweet proteinsprecision fermentationcomputational protein designAI-CPDAI protein designsugar reductionfood techprotein engineeringalternative proteinsynthetic biologysynbiofood ingredient supplierfood formulationzero-calorie ingredient

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amai Proteins Comparables

Compare Amai Proteins with similar companies based on industry and business-model similarity.

Amai Proteins comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Incredo
83%
Oobli
82%
Naturannova
82%

Amai Proteins Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 10, 2023
Series ADec 2, 2022
Series ASep 6, 2021
SeedApr 1, 2020
SeedApr 11, 2019
Convertible Debt
Feb 1, 2019

Key People

Founding team and executive leadership

Moshe Hukaylo

Chief Financial Officer

Executive Team

Yigal Gezundhait

Chief Production Officer, COO

Executive Team

Amai Proteins Investors

Notable investors and investment history

Amai Proteins investors
InvestorRounds
Geshem PartnersSeries A
Israel Innovation AuthorityConvertible Debt, Seed
Sucden VenturesSeries A
Harrison Co.Series A
Israel Innovation AuthoritySeed
Danone Manifesto VenturesSeries A
Welltech VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 2, 2022

    $100M round led by Conquest Global Ventures VCC.

  • Sep 6, 2021

    $11.3M round with participation from SGInnovate and Dragones Venture Partners.

Recent news

Latest coverage and updates

  • hiresSep 15, 2026

    Amai Proteins hired Guttman as board member on Jul 1st '18.

  • hiresSep 10, 2026

    Amai Proteins hired Doug Brown as CEO on Sep 1st '26.

Amai Proteins Filings

Explore SEC and related filing metadata, where available.

Amai Proteins filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amai Proteins's valuation, stock price, and market status.

Is Amai Proteins a public or private company?

Amai Proteins is a private company.

What is the current stock price of Amai Proteins?

Amai Proteins is a private company with no public stock price. No recent secondary market data is available.

How much is Amai Proteins worth (valuation)?

Valuation information for Amai Proteins is not publicly available.

Can I buy Amai Proteins stock?

Amai Proteins shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amai Proteins's last funding round?

Amai Proteins's most recent funding round was Series A on January 10, 2023.

Who are the main investors in Amai Proteins?

Key investors in Amai Proteins include Israel Innovation Authority, Conquest Global Ventures VCC.

Will Amai Proteins IPO soon?

No public IPO plans have been announced for Amai Proteins.

How can I track Amai Proteins secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amai Proteins's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range46
Year Founded2016
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?